Clinical Trials List
Protocol NumberCT-ANK-21
Active
2024-07-01 - 2029-12-31
Phase I/II
Recruiting1
ICD-10C25.0
Malignant neoplasm of head of pancreas
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.0
Malignant neoplasm of head of pancreas
-
Trial Applicant
CMIC Asia-Pacific
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chia-Jui Yen Division of Hematology & Oncology
- Chien-Jui Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36-42 participants
-
Global
36-42 participants
